Suppr超能文献

慢性阻塞性肺疾病急性加重患者接受无创通气时的 ICU 利用情况。

ICU Utilization for Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Receiving Noninvasive Ventilation.

机构信息

Division of Pulmonary/Critical Care, Department of Medicine, Massachusetts General Hospital, Boston, MA.

Department of Emergency Medicine, Massachusetts General Hospital, Boston, MA.

出版信息

Crit Care Med. 2019 May;47(5):677-684. doi: 10.1097/CCM.0000000000003660.

Abstract

OBJECTIVES

We investigated whether patients with chronic obstructive pulmonary disease could safely receive noninvasive ventilation outside of the ICU.

DESIGN

Retrospective cohort study.

SETTING

Twelve states with ICU utilization flag from the State Inpatient Database from 2014.

PATIENTS

Patients greater than or equal to 18 years old with primary diagnosis of acute exacerbation of chronic obstructive pulmonary disease and secondary diagnosis of respiratory failure who received noninvasive ventilation.

INTERVENTIONS

None.

MEASUREMENTS AND MAIN RESULTS

Multilevel logistic regression models were used to obtain hospital-level ICU utilization rates. We risk-adjusted using both patient/hospital characteristics. The primary outcome was in-hospital mortality; secondary outcomes were invasive monitoring (arterial/central catheters), hospital length of stay, and cost. We examined 5,081 hospitalizations from 424 hospitals with ICU utilization ranging from 0.05 to 0.98. The overall median in-hospital mortality was 2.62% (interquartile range, 1.72-3.88%). ICU utilization was not significantly associated with in-hospital mortality (β = 0.01; p = 0.05) or length of stay (β = 0.18; p = 0.41), which was confirmed by Spearman correlation (ρ = 0.06; p = 0.20 and ρ = 0.02; p = 0.64, respectively). However, lower ICU utilization was associated with lower rates of invasive monitor placement by linear regression (β = 0.05; p < 0.001) and Spearman correlation (ρ = 0.28; p < 0.001). Lower ICU utilization was also associated with significantly lower cost by linear regression (β = 14.91; p = 0.02) but not by Spearman correlation (ρ = 0.09; p = 0.07).

CONCLUSIONS

There is wide variability in the rate of ICU utilization for noninvasive ventilation across hospitals. Chronic obstructive pulmonary disease patients receiving noninvasive ventilation had similar in-hospital mortality across the ICU utilization spectrum but a lower rate of receiving invasive monitors and probably lower cost when treated in lower ICU-utilizing hospitals. Although the results suggest that noninvasive ventilation can be delivered safely outside of the ICU, we advocate for hospital-specific risk assessment if a hospital were considering changing its noninvasive ventilation delivery policy.

摘要

目的

我们研究了慢性阻塞性肺疾病患者在 ICU 外是否能安全地接受无创通气。

设计

回顾性队列研究。

地点

2014 年来自国家住院患者数据库的 12 个州 ICU 使用标志。

患者

年龄大于或等于 18 岁,主要诊断为慢性阻塞性肺疾病急性加重,次要诊断为呼吸衰竭,并接受无创通气。

干预

无。

测量和主要结果

使用多水平逻辑回归模型获得医院级别的 ICU 使用率。我们使用患者/医院特征进行风险调整。主要结局是院内死亡率;次要结局是有创监测(动脉/中心导管)、住院时间和成本。我们研究了来自 424 家医院的 5081 例住院患者,其 ICU 使用率从 0.05 到 0.98 不等。总体院内中位死亡率为 2.62%(四分位距 1.72-3.88%)。ICU 使用率与院内死亡率(β=0.01;p=0.05)或住院时间(β=0.18;p=0.41)无显著相关性,这一点也通过 Spearman 相关系数(ρ=0.06;p=0.20 和 ρ=0.02;p=0.64)得到了证实。然而,通过线性回归(β=0.05;p<0.001)和 Spearman 相关系数(ρ=0.28;p<0.001)发现,较低的 ICU 使用率与较低的有创监测放置率相关。较低的 ICU 使用率也与显著较低的成本相关,这一点通过线性回归(β=14.91;p=0.02)得到证实,但 Spearman 相关系数(ρ=0.09;p=0.07)未得到证实。

结论

在医院层面,无创通气的 ICU 使用率存在很大差异。接受无创通气的慢性阻塞性肺疾病患者在 ICU 使用率范围内的院内死亡率相似,但在 ICU 使用率较低的医院接受有创监测的比例较低,可能成本也较低。尽管结果表明无创通气可以在 ICU 外安全实施,但如果医院考虑改变无创通气的实施政策,我们还是提倡对医院进行具体的风险评估。

相似文献

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验